Rosemary Mazanet

Rosemary Mazanet was the founder of Apelles Investment Management LP, founded in 2008, serving as Portfolio Manager from 2008 to 2012.
Current jobs include Non-Independent Director at The Cannabist Company Holdings, Inc. since 2023, Independent Director at Oncternal Therapeutics, Inc. since 2021, Director at Oncolyze, Inc., Director at Angiochem, Inc., President at Dr. Mazanet LLC, President at R Mazanet LLC since 2004, Trustee-Emeritus at the University of Pennsylvania Medical Center, and Trustee at The University of Pennsylvania Health System since 2002.
Former jobs include Chief Executive Officer at Breakthrough Therapeutics LLC from 2004 to 2007, Vice Chairman at Abeona Therapeutics, Inc. from 2005 to 2008, Senior Director-Clinical Research at Amgen, Inc. from 1993 to 1998, Director at Aksys Ltd., Director at GTx, Inc. from 2002 to 2010, Director at Acelerate, Inc., Director at Diabetes America, Inc., Director at Actinium Pharmaceuticals, Inc., Director at Amorcyte, Inc., Director at Cactus Ventures, Inc. from 2012 to 2013, Independent Director at Kairos Pharma Ltd. in 2024, Chief Medical Officer & Executive Vice President at Galena Biopharma, Inc. in 2013, Head of Research at Argenis Capital Advisors LLC from 2007 to 2008, Chief Scientific Officer & General Partner at Oracle Partners LP from 1998 to 2004, Venture Partner at Colt Ventures Ltd., and Trustee at Perelman School of Medicine.
Education includes an undergraduate degree from the University of Virginia, a doctorate from Harvard Medical School, and a doctorate from Perelman School of Medicine.